Don’t Expect Abandonment Of US FDA User Fee Programs If They Sunset

peering over cliff
The prospect of a temporary lapse in authorization has stakeholders wondering what happens where the user fees end. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from User Fees

More from Pathways & Standards